Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capmatinib is an oral, selective, ATP-competitive c-Met kinase inhibitor that inhibits c-Met kinase for the treatment of metastatic non-small cell lung cancer with mutations in MET···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：440
Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.How many versions of Pemigatinib are there?From the perspective of drug specifications, Pemigatinib i···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：363
Capmatinib is a lung cancer drug that targets specific genetic mutations, especially for patients with non-small cell lung cancer with METex14 skipping mutations. The drug helps to···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：466
Pemigatinibis a targeted drug for the treatment of cholangiocarcinoma and belongs to the FGFR (fibroblast growth factor receptor) inhibitor class.What is Pemigatinib?Pemigatinibis ···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：363
Capmatinib is a targeted therapy for the treatment of non-small cell lung cancer harboring mutations in MET exon 14. It helps patients control the spread of pathological cells by i···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：421
Exkivity reduces the growth of non-small cell lung cancer by binding to and inhibiting EGFR exon 20 insertion mutations.What interactions can occur with other medicationsExkivity m···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：415
Exkivity works by binding to and blocking EGFR exon 20 insertion mutations, which helps to slow the growth of cancer cells.Which drugs interact with ExkivityExkivity may interact w···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：409
Exkivity was granted accelerated FDA approval in 2021 based on results from the clinical trial NCT02716116. It is used with the Oncomine Dx Target Test, which identifies patients w···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：429
Exkivity capsules can be used by adults with non-small cell lung cancer that has spread to other parts of the body (metastatic) and cannot be removed with surgery, whose disease ha···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：329
Exkivity (mobocertinib) is a tyrosine kinase inhibitor (TKI) used to treat non-small cell lung cancer (NSCLC) that has a specific EGFR gene mutation.What does Mobotinib pay attenti···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：361
Exkivity (mobocertinib) is a tyrosine kinase inhibitor (TKI) used to treat non-small cell lung cancer (NSCLC) that has a specific EGFR gene mutation. Exkivity reduces the growth of···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：349
Capmatinib targets the activity of MET receptors and blocks the tumor cell growth signaling pathway driven by MET receptors, enabling effective treatment for patients with non-smal···【more】
Article source：Captain MedicineRelease date：2024-08-08Recommended：424
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
